Harm Reduction
Events
-
-
Opioid Agonist Maintenance Treatment (OAMT) as an Essential Health Service (World Health Organization (WHO), MdM and INHSU)
This session will present WHO recommendations for uninterrupted OAMT access, discuss the impact of service disruptions, and highlight global efforts to ensure life saving interventions for people who use drugs are maintained.
-
-
Hep C Prevention for LGB and TGNC Individuals and Communities (NYS AIDS Institute)
This 2-hour webinar from the Regional Training Center will review the basic information about Hep C that health and human service providers should discuss with program participants who identify as Lesbian, Gay, Bisexual (LGB) or Transgender/Gender Non-Conforming (TGNC).
-
-
WHO Revised Operational Guide: Needle and Syringe Programmes for People Who Inject Drugs (WHO)
This webinar will highlight the operational guides’ objectives, provide country examples of success, and discuss the broader context for scaling NSPs.
-
-
Overdose Prevention Training Series Part 2 (NYC Health Dept)
This training series for hepatitis peer, patient, and telephone navigators will discuss harm reduction principles and overdose prevention strategies that support conversations with Hep C patients around risk factors for overdose.
-
Overdose Prevention Training Series Part 3 (NYC Health Dept)
This training series for hepatitis peer, patient, and telephone navigators will discuss harm reduction principles and overdose prevention strategies that support conversations with Hep C patients around risk factors for overdose.
-
-
The Intersection of the Opioid Crisis and Hep C (NYS Health Dept)
The goal of this two-hour webinar for health and human services providers is to inform providers about the impact of the nation’s opiate crisis on the Hep C epidemic, so that they may better serve and address barriers for clients who are living with Hep C and/or have a relationship with opioid use.
